期刊文献+

多囊卵巢综合征与非酒精性脂肪性肝病 被引量:2

Polycystic ovary syndrome and non-alcoholic fatty liver disease
原文传递
导出
摘要 非酒精性脂肪性肝病(non-alcoholic fatty liverdisease,NAFLD)是一种与胰岛素抵抗和遗传易感密切相关的获得性代谢应激性肝损伤,疾病谱包括单纯性脂肪肝、非酒精性脂肪性肝炎(non-alcoholicsteatohepatitis,NASH)及其相关肝硬化.NAFLD的肝组织学改变与酒精性肝病相似,但无过量饮酒史和其他明确损肝因素存在.随着生活方式的改变,NAFLD已成为西方发达国家和我国富裕地区慢性肝病的首要病因 [1],导致失代偿期肝硬化、2型糖尿病、动脉粥样硬化以及代谢综合征相关恶性肿瘤的发生率升高.
出处 《中华糖尿病杂志》 CAS 2009年第6期-,共3页 CHINESE JOURNAL OF DIABETES MELLITUS
  • 相关文献

参考文献13

  • 1Fan JG;Falrell GC.Epidemiology of non-alcoholic fatty liver disease in China[J]Journal of Hepatology,2009(01):204-210.
  • 2Azziz R,Woods KS,Reyna R. The prevalence and features of the polycystic ovary syndrome in an unselected population[J].Journal of Clinical Endocrinology and Metabolism,2004.2745-2749.
  • 3Ehrmann DA. Polycystic ovary syndrome[J].New England Journal of Medicine,2005.1223-1236.
  • 4Setji TL,Brown AJ. Polycystic ovary syndrome:diagnosis and treatment[J].American Journal of Medicine,2007,(2):128-132.doi:10.1016/j.amjmed.2006.06.029.
  • 5Essah PA,Nestler JE. The metabolic syndrome in polycystic ovary syndrome[J].Journal of Endocrinological Investigation,2006.270-280.
  • 6Neuschwander-Tetri BA. Fatty liver and the metabolic syndrome[J].Current Opinion in Gastroenterology,2007.193-198.
  • 7Setji TL,Uand ND,Sanders LL. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome[J].Journal of Clinical Endocrinology and Metabolism,2006.1741-1747.doi:10.1210/jc.2005-2774.
  • 8Gambarin-Gelwan M,Kinkhabwala SV,Schiano TD. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome[J].Clinical Gastroenterology and Hepatology,2007.496-501.
  • 9Cerda C,P(e)rez-Ayuso RM,Riquelme A. Nonalcoholic fatty liver disease in women with polycysticovary syndrome[J].Journal of Hepatology,2007.412-417.
  • 10郑若姮,丁彩飞.多囊卵巢综合征患者非酒精性脂肪性肝病发病情况分析[J].中华妇产科杂志,2008,43(2):98-101. 被引量:10

二级参考文献22

  • 1Welt CK, Gudmundsson JA, Arason G. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab,2006,91:4842-4848.
  • 2Ehrmann DA. Polycystic ovary syndrome N Engl J Med,2005, 352 : 1223-1236.
  • 3Setji TL, Brown AJ. Polycystic ovary syndrome: diagnosis and treatment. Am J Meal,2007, 120:128-132.
  • 4Essah PA, Nestler JE. The metabolic syndrome in polycysfic ovary syndrome. J Endocrinol Invest,2006,29:270-280.
  • 5Angulo P. Nonalcoholic fatty liver disease. N Engl J Med ,2002, 346 : 1221-1231.
  • 6Agarwal N, Sharma BC. Insulin resistance and clinical aspects of non-alcoholic steatohepatitis ( NASH ). Hepatol Res, 2005,33 : 92-96.
  • 7Setji TL, Holland ND, Sanders LL, et al. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2006, 91:1741-1747.
  • 8Cerda C, Perez-Ayuso RM, Riquelme A, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol, 2007,47:412-417.
  • 9The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum reprod, 2004,19:41-47.
  • 10Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 2000,23:57-63.

共引文献10

同被引文献5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部